Researcher
Marinee Chuah
- Keywords:Medicine
- Disciplines:Other basic sciences not elsewhere classified
Affiliations
- Basic (bio-) Medical Sciences (Department)
Member
From1 Jan 2014 → Today - Division of Gene Therapy & Regenerative Medicine (Research group)
Responsible
From19 Apr 2011 → Today - Cell Biology and Histology (Department)
Member
From1 Oct 2010 → 31 Dec 2013 - Cell Biology and Histology (Department)
Member
From1 Oct 2010 → 30 Apr 2012
Projects
1 - 10 of 10
- CardioReGenix: Development of Next-Generation Gene Therapies for Cardiovascular Disease (OZR EU Bonus).From1 Jan 2019 → Today
- CardioReGenix: Development of Next-Generation Gene Therapies for Cardiovascular DiseaseFrom1 Jan 2019 → TodayFunding: H2020 - Health, demographic change and wellbeing
- "CURE-DMD": Development of Next-Generation Gene Therapy for Duchenne Muscular DystrophyFrom1 Jan 2017 → 31 Dec 2020Funding: FWO research project
- Financing IOF-program GEAR: Hyperactieve Expressie-modulesFrom1 Apr 2014 → 31 Mar 2020Funding: IOF - Industrial Research Fund
- SRP (Groeiers): Next-generation gene therapy by computational vector design and immune stealth nanotechnologyFrom1 Mar 2014 → 28 Feb 2019Funding: BOF - Concerted Research Project from 1994
- In vivo genome engineering based on the CRISPR / Cas system: a new platform for functional genome analysis and gene therapyFrom1 Jan 2014 → 31 Dec 2017Funding: FWO research project
- Development of novel "immune stealth" nanotechnology for gene therapy of hemophilia: pre-clinical validation and underlying mechanismsFrom1 Oct 2013 → 30 Jun 2014Funding: FWO fellowships
- Cardiovascular and muscle-specific "targeting" for gene therapy of neuromuscular disordersFrom1 Jan 2013 → 31 Dec 2016Funding: FWO research project
- Myotonic dystrophy type 1 (DM1)-specific induced pluripotent stem cells (iPS): an innovative platform for myogenic and cardiomyogenic differentiation and validation of novel therapeutic approachesFrom1 Jan 2012 → 31 Dec 2015Funding: FWO research project
- Immune stealth nanotechnology for gene therapy of hemophilia 'A': mechanisms and translational implicationsFrom1 Jan 2012 → 31 Dec 2015Funding: FWO research project
Publications
1 - 10 of 79
- Comprehensive transcriptome-wide analysis of spliceopathy correction of myotonic dystrophy using CRISPR-Cas9 in iPSCs-derived cardiomyocytes(2022)
Authors: Sumitava Dastidar, Debanjana Majumdar, Jaitip Tipanee, Kshitiz Singh, Arnaud F Klein, Denis Furling, Marinee K Chuah, Thierry VandenDriessche
Pages: 75-91Number of pages: 17 - Dose-dependent microdystrophin expression enhancement in cardiac muscle by a cardiac specific regulatory element(2021)
Authors: Alberto Malerba, Chiara Sidoli, Ngoc B Lu-Nguyen, Shanthi Herath, Anita Le Heron, Hayder Abdul-Razak, Susan Jarmin, Thierry Vandendriessche, Marinee K L Chuah, George Dickson, et al.
Pages: 1138-1146Number of pages: 9 - Gene Therapy For Hemophilia B Using CB 2679d-GT: A Novel Factor IX Variant With Higher Potency Than Factor IX Padua(2021)
Authors: Nisha Nair Dastidar, Dries De Wolf, Phuong Anh Nguyen, Hong Quang Pham, Ermira Samara-Kuko, Jeff Landau, Grant E.Blouse, Marinee K Chuah, Thierry VandenDriessche
Pages: 2902-2906Number of pages: 5 - Identification of a myotropic AAV by massively parallel in vivo evaluation of barcoded capsid variants(2020)
Authors: Jonas Weinmann, Sabrina Weis, Josefine Sippel, Warut Tulalamba, Anca Remes, Jihad El Andari, Anne-Kathrin Herrmann, Hong Quang Pham, Christopher Borowski, Susanne Hille, et al.
- Genetic and Epigenetic Modification of Rat Liver Progenitor Cells via HNF4α Transduction and 5’ Azacytidine Treatment: An Integrated miRNA and mRNA Expression Profile Analysis(2020)
Authors: Jennifer Bolleyn, Matthias Rombaut, N. Nair, Steven Branson, Anja Heymans, Anja Heymans, Marinee K Chuah, T. Vandendriessche, Vera Rogiers, Joery De Kock, et al.
Pages: 62-80Number of pages: 18 - Distinct transduction of muscle tissue in mice after systemic delivery of AAVpo1 vectors(2020)
Authors: Warut Tulalamba, Jonas Weinmann, Hong Quang Pham, Jihad El Andari, T. Vandendriessche, Marinee K Chuah, Dirk Grimm
Pages: 170-179Number of pages: 10 - Validation of miR-20a as a Tumor Suppressor Gene in Liver Carcinoma Using Hepatocyte-Specific Hyperactive piggyBac Transposons(2020)
Authors: Jaitip Tipanee, Mario Di Matteo, Warut Tulalamba, Ermira Samara-Kuko, Jiri Keirsse, Jo A Van Ginderachter, Marinee K Chuah, T. Vandendriessche
Pages: 1309-1329Number of pages: 21 - Next-generation muscle-directed gene therapy by in silico vector design(2019)
Authors: Shilpita Sarcar, Warut Tulalamba, Melvin Rincon Acelas, Jaitip Tipanee, Hong Quang Pham, Hanneke Evens, Dimitri Boon, E. Samara-Kuko, Marleen Keyaerts, Mariana Loperfido, et al.
Pages: 492Number of pages: 18 - Muscle Gene Therapy(2019)
Authors: Thierry VandenDriessche, Yoke Chin Chai, Dimitri Boon, Marinee K Chuah
Pages: 81-97Number of pages: 17 - Efficient CRISPR/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells(2018)
Authors: Sumitava Dastidar, Simon Ardui, Kshitiz Singh, Debanjana Majumdar, Nisha Nair Dastidar, Yanfang Fu, Deepak Reyon, Ermira Samara, Mattia FM Gerbil, Arnaud F. Klein, et al.
Pages: 8275-8298Number of pages: 24